RGA
GILD icon

Red Granite Advisors’s Gilead Sciences GILD Stock Holding History

Red Granite Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$15.3M Buy
243,543
+1,050
+0.4% +$62.8K 3.39% 5
2013
Q2 		$12.4M Buy
+242,493
New +$12.6M 3.1% 7

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Red Granite Advisors's GILD Position: Q3 2013 in Review

Red Granite Advisors increased its Gilead Sciences (GILD) stake by 0.43% in Q3 2013, buying an estimated $62.8K and bringing the position to 243,543 shares worth $15.3M. The position accounts for 3.39% of the portfolio, ranked #5.

Red Granite Advisors first reported a position in GILD in Q2 2013 and has held it in 2 quarters since. 982 funds tracked by Wall St. Rank hold GILD as of Q3 2013.

  • Red Granite Advisors held 243,543 shares of Gilead Sciences worth $15.3M as of Q3 2013.
  • Red Granite Advisors bought 1,050 Gilead Sciences shares in Q3 2013, an estimated $62.8K.
  • Gilead Sciences made up 3.39% of Red Granite Advisors's portfolio in Q3 2013, its #5 holding.
  • Red Granite Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 2 quarters since.
  • 982 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2013.

Based on Red Granite Advisors's 13F filing for Q3 2013, filed 6 Nov 2013.